Home » Authors » Nuala Moran

Articles by Nuala Moran

Phytopharm Sees Encouraging Results In Phase I P54 Study

Jan. 10, 2001

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Jan. 10, 2001

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Jan. 10, 2001

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Jan. 10, 2001

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Jan. 10, 2001

Phytopharm Sees Encouraging Results In Phase I P54 Study

Jan. 10, 2001

Oxxon Plans Moves Into Phase II Following £4.7M Private Funding

Jan. 3, 2001

Scotia Sells Assets, Buys Time While Awaiting Foscan Decision

Jan. 3, 2001

Oxxon Plans Moves Into Phase II Following £4.7M Private Funding

Jan. 3, 2001

Scotia Sells Assets, Buys Time While Awaiting Foscan Decision

Jan. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...